Featured Research

from universities, journals, and other organizations

UT Southwestern Researchers Develop New Method Of Delivering Vaccines

Date:
January 2, 2002
Source:
University Of Texas Southwestern Medical Center At Dallas
Summary:
Researchers at UT Southwestern Medical Center at Dallas have developed a quicker, more cost-efficient method of delivering dendritic cell-based vaccines – a discovery that moves anti-tumor vaccines closer to a practical reality.

DALLAS – Dec. 28, 2001 – Researchers at UT Southwestern Medical Center at Dallas have developed a quicker, more cost-efficient method of delivering dendritic cell-based vaccines – a discovery that moves anti-tumor vaccines closer to a practical reality.

Until now, the conventional method to develop these vaccines involved extracting dendritic cells, which initiate immune responses to bacteria, viruses and cancer cells, from the body, then culturing and expanding the cells in a petri dish, loading them with tumor-associated antigens – substances the immune system recognize on cancer cells – and finally administering them through a vaccine.

Dr. Akira Takashima, professor of dermatology at UT Southwestern, reported in today’s Nature Biotechnology that this expensive and time-consuming process has prevented broader clinical applications for dendritic cell-based vaccines.

In the UT Southwestern study, Takashima developed and tested a new procedure in mice that enabled researchers to manipulate dendritic cells in the skin rather than in a petri dish. This new process streamlines the conventional method from 10 days to 24 hours.

Dendritic cells are specialized white blood cells that signal T lymphocytes, critical components of the immune system, to multiply and initiate an immune response. The epidermis, or outermost layer of normal skin, contains immature dendritic cells known as Langherhans cells.

Upon exposure to a topical chemical called a hapten, Langerhans cells mature and migrate from the epidermis to draining lymph nodes. Small molecules called chemokines attract the trafficking cells and help mediate this process.

“Lymphatic endothelial cells produce a chemokine known as MIP-3, which binds to a corresponding receptor called CCR7. Langerhans cells utilize CCR7 to migrate from the epidermis to draining lymph nodes,” said Takashima. “We incorporated this chemokine into a polymer rod so that it could be released in a controlled fashion.”

The researchers created an artificial trap for Langerhans cells by implanting under the skin a polymer rod synthesized with ethylene-vinyl-acetate to release MIP-3. After the rod was implanted, researchers applied hapten to trigger Langerhans-cell migration. The rod temporarily entrapped the Langerhans cells, which eventually homed to the lymph nodes. The procedure resulted in accumulation of Langerhans cells around the rod, Takashima said.

In a second experiment, a polymer rod releasing a tumor-associated antigen was then implanted under the skin.

“We thought these Langerhans cells would carry the tumor-associated antigen to the draining lymph nodes and initiate protective immunity against tumor development. Our subsequent experiments with several tumor models have, indeed, demonstrated the preclinical efficacy of this strategy. We believe that our in situ Langerhans-cell vaccine format represents a breakthrough in the tumor vaccines field, thus moving it toward practical medicine,” said Takashima.

Dr. Tadashi Kumamoto, postdoctoral researcher in dermatology at UT Southwestern, was also involved in the study, which was supported by grants from the National Institutes of Health.


Story Source:

The above story is based on materials provided by University Of Texas Southwestern Medical Center At Dallas. Note: Materials may be edited for content and length.


Cite This Page:

University Of Texas Southwestern Medical Center At Dallas. "UT Southwestern Researchers Develop New Method Of Delivering Vaccines." ScienceDaily. ScienceDaily, 2 January 2002. <www.sciencedaily.com/releases/2002/01/020102075532.htm>.
University Of Texas Southwestern Medical Center At Dallas. (2002, January 2). UT Southwestern Researchers Develop New Method Of Delivering Vaccines. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2002/01/020102075532.htm
University Of Texas Southwestern Medical Center At Dallas. "UT Southwestern Researchers Develop New Method Of Delivering Vaccines." ScienceDaily. www.sciencedaily.com/releases/2002/01/020102075532.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins